Internal Medicine, Endocrinology, Diabetes, & Metabolism · Charleston, SC
NPI
1467814590
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
863 services
Medicare patients, 2024
343
Average age 72
Drug cost, 2024
$1.0M
1,586 prescriptions
Company payments, 2024
$111
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Colleen Gavigan was code 99214 (office e&m - established), 270 times for 215 patients. In total Colleen Gavigan billed 863 services in 15 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 270 | 215 | $75.20 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 244 | 201 | $11.04 | $2,693 |
| 95251 Test - Miscellaneous | Office | 68 | 43 | $21.75 | $1,479 |
| 83036 Blood Count | Office | 59 | 45 | $9.40 | $554 |
| 99204 Office E&M - New | Office | 42 | 42 | $85.83 | $3,605 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 34 | 32 | $12.03 | $409 |
| 99214 Office E&M - Established | Facility | 30 | 28 | $65.85 | $1,975 |
| 99215 Office E&M - Established | Office | 30 | 27 | $104.16 | $3,125 |
| 99213 Office E&M - Established | Office | 25 | 25 | $67.71 | $1,693 |
By year: 2022 $34K for 393 services; 2023 $62K for 806 services; 2024 $40K for 863 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 59 | 45 | $9.40 | $554 |
Medicare prescription drug claims, 2024
In 2024, the drug Colleen Gavigan prescribed most often to Medicare patients was Levothyroxine Sodium, with 247 prescriptions and refills. In total Colleen Gavigan wrote 1,586 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 247 | 585 | 56 | $3,126 |
| Mounjaro Tirzepatide | 191 | 246 | 25 | $252K |
| Ozempic Semaglutide | 91 | 132 | 17 | $116K |
| Jardiance Empagliflozin | 82 | 137 | 17 | $77K |
| Alendronate Sodium Generic | 76 | 200 | 32 | $671 |
| Forteo Teriparatide | 56 | 67 | Under 11 | $257K |
| Methimazole Generic | 49 | 133 | 14 | $619 |
| Metformin Hcl Er Metformin Hcl | 48 | 133 | 14 | $1,501 |
| Prednisone Generic | 44 | 63 | Under 11 | $395 |
| Synthroid Levothyroxine Sodium | 40 | 118 | 14 | $5,124 |
| Metformin Hcl Generic | 37 | 109 | 12 | $206 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 36 | 104 | 14 | $4,744 |
| Hydrocortisone Generic | 30 | 75 | Under 11 | $1,890 |
| Liothyronine Sodium Generic | 23 | 35 | Under 11 | $743 |
| Atorvastatin Calcium Generic | 23 | 65 | Under 11 | $263 |
Brand drugs: 826 claims; generic drugs: 692 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Colleen Gavigan $111 ($111 in general payments such as food, travel and fees) from 1 company. The largest payer was Kyowa Kirin, Inc. with $111.
| Company | Payments | Amount |
|---|---|---|
| Kyowa Kirin, Inc. 4151.T | 1 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.